Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Merit Medical Systems, Inc. manufactures and markets products used in diagnostic and interventional cardiology and radiology procedures. The Company"s primary products include inflation devices, guide wires, thrombolytic catheters and fluid dispensing systems, and angiography accessories, among others. Merit"s products are sold worldwide.
Website: merit.com



Growth: Pretty weak revenue growth rate 8.7%, there is slowdown compared to average historical growth rates 10.0%. The revenue growth dynamics is moderately stable Site traffic for the last 3 months showed a change of -13.8%

Profitability: LTM EBITDA margin is positive, +18.3%. On average the margin is improving unsteadily. Gross margin is high, +46.9%. In the last quarter the company beat the estimated EPS, +16.4%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.11 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 52.8% higher than minimum and 7.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.9x by EV / Sales multiple , the company can be 24.2% overvalued

Insiders: For the last 3 months insiders sold company shares on $3.8 mln (-0.087% of cap.)

Key Financials (Download financials)

Ticker: MMSI
Share price, USD:  (+2.5%)78.97
year average price 74.69  


year start price 84.82 2023-05-07

max close price 85.24 2023-06-07

min close price 62.92 2023-10-12

current price 78.97 2024-05-06
Common stocks: 57 958 000

Dividend Yield:  0.0%
FCF Yield LTM: 0.3%
EV / LTM EBITDA: 20.7x
EV / EBITDA annualized: 20.3x
Last revenue growth (y/y):  8.7%
Last growth of EBITDA (y/y):  53.8%
Historical revenue growth:  10.0%
Historical growth of EBITDA:  41.8%
EV / Sales: 3.8x
Margin (EBITDA LTM / Revenue): 18.3%
Fundamental value created in LTM:
Market Cap ($m): 4 577
Net Debt ($m): 292
EV (Enterprise Value): 4 869
Price to Book: 3.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-01Zacks Investment Research

Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up

2024-04-30Seeking Alpha

Merit Medical Systems, Inc. (MMSI) Q1 2024 Earnings Call Transcript

2024-04-30Zacks Investment Research

Merit Medical (MMSI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

2024-04-30Zacks Investment Research

Merit Medical (MMSI) Beats Q1 Earnings and Revenue Estimates

2024-04-10Zacks Investment Research

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

2024-03-27Zacks Investment Research

Here's Why Merit Medical (MMSI) is a Strong Value Stock

2024-03-20Zacks Investment Research

Merit Medical (MMSI) Launches FDA-Cleared Micro-Access System

2024-03-18GlobeNewsWire

Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024

2024-03-08Zacks Investment Research

Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term

2024-03-07Zacks Investment Research

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2024-04-30 2024-02-28 2023-10-26 2023-07-28 2023-04-28 2023-02-24 2022-10-28
acceptedDate 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 324M 323M 315M 320M 298M 293M 287M
costOfRevenue 172M 188M 173M 167M 159M 159M 159M
grossProfit 152M 135M 142M 153M 138M 135M 129M
grossProfitRatio 0.469 0.418 0.451 0.477 0.465 0.459 0.448
researchAndDevelopmentExpenses 21M 22M 20M 20M 21M 20M 19M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 94M 81M 87M 101M 90M 83M 90M
otherExpenses -804 000 909 000 -255 000 -451 000 997 000 0 0
operatingExpenses 116M 102M 107M 121M 111M 104M 109M
costAndExpenses 288M 291M 280M 288M 271M 263M 268M
interestIncome 7M 2M 181 000 221 000 131 000 123 000 116 000
interestExpense 8M 6M 5M 4M 2M 2M 2M
depreciationAndAmortization 27M 26M 27M 28M 25M 25M 24M
ebitda 69M 59M 62M 57M 51M 56M 43M
ebitdaratio 0.213 0.183 0.198 0.177 0.172 0.190 0.148
operatingIncome 36M 33M 35M 29M 26M 30M 19M
operatingIncomeRatio 0.111 0.101 0.111 0.090 0.089 0.104 0.065
totalOtherIncomeExpensesNet -687 000 -1M -817 000 -4M -883 000 -262 000 -1M
incomeBeforeTax 34M 31M 30M 25M 26M 30M 18M
incomeBeforeTaxRatio 0.106 0.097 0.096 0.078 0.086 0.103 0.061
incomeTaxExpense 6M 4M 4M 5M 5M -3M 2M
netIncome 28M 28M 26M 20M 21M 33M 15M
netIncomeRatio 0.087 0.085 0.082 0.063 0.070 0.114 0.053
eps 0.490 0.480 0.450 0.350 0.360 0.580 0.270
epsdiluted 0.480 0.470 0.440 0.350 0.360 0.580 0.270
weightedAverageShsOut 58M 58M 58M 58M 57M 57M 57M
weightedAverageShsOutDil 59M 58M 58M 58M 58M 58M 58M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2024-04-30 2024-02-28 2023-10-26 2023-07-28 2023-04-28 2023-02-24 2022-10-28
acceptedDate 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 582M 589M 59M 72M 58M 58M 51M
shortTermInvestments 1M 2M 2M 0 0 0 0
cashAndShortTermInvestments 582M 589M 59M 72M 58M 58M 51M
netReceivables 192M 189M 191M 188M 186M 178M 171M
inventory 303M 304M 304M 306M 290M 266M 247M
otherCurrentAssets 24M 26M 28M 25M 20M 22M 31M
totalCurrentAssets 1 105M 1 108M 585M 595M 557M 529M 500M
propertyPlantEquipmentNet 456M 447M 447M 447M 450M 448M 441M
goodwill 382M 382M 381M 382M 360M 360M 358M
intangibleAssets 317M 326M 340M 355M 264M 276M 284M
goodwillAndIntangibleAssets 699M 708M 721M 737M 624M 636M 642M
longTermInvestments -6M 23M 698 000 4M 0 16M 0
taxAssets 7M 7M 6M 6M 7M 7M 5M
otherNonCurrentAssets 64M 32M 48M 49M 46M 29M 44M
totalNonCurrentAssets 1 221M 1 217M 1 223M 1 243M 1 127M 1 135M 1 133M
otherAssets 0 0 0 0 0 0 0
totalAssets 2 326M 2 325M 1 809M 1 838M 1 684M 1 664M 1 633M
accountPayables 48M 66M 49M 62M 66M 69M 63M
shortTermDebt 12M 12M 15M 15M 22M 22M 22M
taxPayables 9M 5M 4M 2M 9M 7M 4M
deferredRevenue -12M 5M -49M -62M 0 0 0
otherCurrentLiabilities 135M 120M 172M 175M 128M 130M 128M
totalCurrentLiabilities 183M 204M 187M 190M 216M 221M 213M
longTermDebt 860M 823M 340M 392M 244M 246M 265M
deferredRevenueNonCurrent 2M 2M 2M 2M 2M 2M 2M
deferredTaxLiabilitiesNonCurrent 6M 6M 18M 18M 18M 18M 31M
otherNonCurrentLiabilities 35M 90M 32M 32M 32M 32M 246M
totalNonCurrentLiabilities 903M 920M 391M 444M 297M 299M 331M
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 73M 56M 69M 68M 69M 71M 70M
totalLiabilities 1 086M 1 123M 579M 634M 512M 520M 544M
preferredStock 1.000 0 0 0 0 0 0
commonStock 649M 638M 695M 692M 681M 675M 658M
retainedEarnings 603M 575M 548M 522M 501M 481M 447M
accumulatedOtherComprehensiveIncomeLoss -12M -11M -13M -10M -11M -12M -17M
othertotalStockholdersEquity -1.000 0 0 0 0 0 0
totalStockholdersEquity 1 240M 1 202M 1 230M 1 204M 1 172M 1 144M 1 089M
totalEquity 1 240M 1 202M 1 230M 1 204M 1 172M 1 144M 1 089M
totalLiabilitiesAndStockholdersEquity 2 326M 2 325M 1 809M 1 838M 1 684M 1 664M 1 633M
minorityInterest 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 2 326M 2 325M 1 809M 1 838M 1 684M 1 664M 1 633M
totalInvestments 1M 23M 698 000 4M 0 16M 0
totalDebt 873M 891M 355M 407M 266M 269M 287M
netDebt 291M 302M 297M 335M 209M 210M 235M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2024-04-30 2024-02-28 2023-10-26 2023-07-28 2023-04-28 2023-02-24 2022-10-28
acceptedDate 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 28M 28M 26M 20M 21M 33M 15M
depreciationAndAmortization 27M 26M 27M 25M 23M 23M 23M
deferredIncomeTax 0 -13M 133 000 121 000 0 0 0
stockBasedCompensation 5M 6M 6M 6M 4M 4M 5M
changeInWorkingCapital -26M 14M -8M -41M -34M -20M -9M
accountsReceivables -4M 4M 2M -1M -5M -6M 409 000
inventory -382 000 2M 1M -13M -23M -17M -16M
accountsPayables -14M 13M -13M -4M 2M 3M 6M
otherWorkingCapital 1M -6M 2M -23M -9M -157 000 800 000
otherNonCashItems 1M 1M 902 000 8M 853 000 -12M 1M
netCashProvidedByOperatingActivities 36M 62M 51M 17M 15M 28M 35M
investmentsInPropertyPlantAndEquipment -13M -8M -9M -6M -13M -12M -17M
acquisitionsNet -3M 451 000 71 000 -136M -2M -4M 0
purchasesOfInvestments 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0
otherInvestingActivites -6M -1 000 000 -729 000 -1M -71 000 -1M -17M
netCashUsedForInvestingActivites -22M -8M -9M -143M -15M -17M -17M
debtRepayment -24M -535M -73M -268M -50M -154M -74M
commonStockIssued 8M 4M 2M 5M 4M 13M 3M
commonStockRepurchased -2M 0 -4M 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites -2M 1 004M 24M 404M 46M 135M 43M
netCashUsedProvidedByFinancingActivities -18M 473M -55M 142M -497 000 -6M -27M
effectOfForexChangesOnCash -1M 2M -684 000 -2M 376 000 2M -3M
netChangeInCash -5M 528M -13M 14M -432 000 7M -12M
cashAtEndOfPeriod 584M 589M 61M 74M 60M 61M 54M
cashAtBeginningOfPeriod 589M 61M 74M 60M 61M 54M 65M
operatingCashFlow 36M 62M 51M 17M 15M 28M 35M
capitalExpenditure -13M -8M -9M -6M -13M -12M -17M
freeCashFlow 24M 54M 42M 12M 2M 16M 19M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Earning call transcript

2024 q1
2024-04-30 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-10-26 ET (fiscal 2023 q3)
2023 q2
2023-07-26 ET (fiscal 2023 q2)
2023 q1
2023-04-26 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-27 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-04-30 20:05 ET
Merit Medical Reports Results for First Quarter Ended March 31, 2024
2024-03-19 13:25 ET
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
2024-03-18 21:19 ET
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
2024-03-05 14:25 ET
Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
2024-02-28 21:05 ET
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance
2024-02-28 21:05 ET
Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026
2024-02-15 14:25 ET
Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System
2024-01-16 21:05 ET
First Patient Enrolled in Merit Medical’s MOTION Study
2024-01-08 14:00 ET
Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024
2024-01-03 21:05 ET
Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference
2023-12-18 21:05 ET
Merit Medical Announces Process for Chief Executive Officer Succession Planning
2023-12-06 14:00 ET
Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029
2023-12-04 21:05 ET
Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes
2023-10-26 20:05 ET
Merit Medical Reports Results for Third Quarter Ended September 30, 2023
2023-10-10 13:25 ET
Merit Medical Launches Expanded Maestro® Microcatheter Line
2023-10-05 13:25 ET
Merit Medical Systems to Announce Third Quarter 2023 Results on October 26, 2023
2023-09-06 13:25 ET
Merit Medical Launches the Aspira® Evacuated Drainage Bottle 
2023-08-03 13:25 ET
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
2023-07-25 20:05 ET
Merit Medical Reports Results For Second Quarter June 30, 2023
2023-07-06 17:11 ET
Merit Medical Systems to Announce Second Quarter 2023 Results On July 25, 2023
2023-06-08 20:01 ET
Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.
2023-06-07 20:23 ET
Merit Medical Announces New Five-Year Senior Secured Credit Agreement
2023-04-26 20:05 ET
Merit Medical Reports Results for First Quarter March 31, 2023
2023-04-06 13:25 ET
Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
2023-03-20 13:25 ET
Merit Medical Launches Expanded SwiftNINJA® Steerable Microcatheter Offering
2023-02-22 21:05 ET
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2022 Issues Fiscal Year 2023 Guidance
2023-02-16 14:25 ET
Merit Medical Receives FDA Breakthrough Device Designation for the New SCOUT® MD™ Surgical Guidance System
2023-02-03 16:30 ET
Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
2022-12-05 14:25 ET
First Patient Enrolled in Merit Medical’s Multicenter Observational Study to Evaluate the Use of EmboCube® Embolization Gelatin to Control Bleeding or Hemorrhage
2022-11-28 14:25 ET
Merit Medical Launches the basixALPHA™ Inflation Device
2022-11-22 14:25 ET
Fred Lampropoulos Receives Manufacturing Leader of the Year Award from the Utah Manufacturers Association 
2022-11-21 14:25 ET
Merit Medical Launches the PreludeSYNC EZ™ Radial Compression Device
2022-11-02 20:05 ET
Summary Notice to Current Merit Medical Systems, Inc. Stockholders of Derivative Action and Settlement Hearing
2022-11-01 13:25 ET
Merit Medical Announces the Appointment of Joe Wright to Chief Commercial Officer
2022-10-26 20:05 ET
Merit Medical Reports Results for Quarter Ended September 30, 2022
2022-10-13 13:25 ET
Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
2022-09-27 13:25 ET
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System
2022-09-12 13:25 ET
Merit Medical Launches the Prelude Roadster™ Guide Sheath
2022-08-08 13:25 ET
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
2022-07-27 20:15 ET
Merit Medical Reports Results for Quarter Ended June 30, 2022
2022-07-20 15:00 ET
Merit Medical Launches Smallest and Shortest Configuration of Elation® Pulmonary Balloon Dilator to Help Meet Critical Patient Need
2022-07-14 13:25 ET
Merit Medical Systems to Announce Second Quarter Results on July 27, 2022
2022-07-13 13:25 ET
First Patient Enrolled in the Streamlined Localization (STREAMLoc) Registry Study Using SCOUT® at Biopsy in Canada
2022-07-07 15:00 ET
New SCOUT® Mini Reflector Provides Physicians with a Compact Design for Greater Utility
2022-07-05 16:02 ET
First Patient Enrolled in Merit Medical’s WRAPSODY™ Registry (WRAP) Study
2022-06-29 21:30 ET
Merit Medical Celebrates Completion of Xeriscape Landscaping Project
2022-04-27 20:05 ET
Merit Medical Reports Results for Quarter Ended March 31, 2022
2022-04-21 20:05 ET
Merit Medical Announces Chief Operating Officer Transition
2022-04-21 13:25 ET
Merit Medical’s Chief Legal Officer and Corporate Secretary, Brian Lloyd, Receives Corporate Counsel Award from Utah Business Magazine
2022-04-18 13:25 ET
Merit Medical Announces Launch of ReSolve® Thoracostomy Tray
2022-04-13 17:28 ET
Merit Medical Systems to Announce First Quarter Results on April 27, 2022
2022-04-11 13:25 ET
Merit Medical Receives FDA Clearance for SCOUT Bx™ Delivery System
2022-03-07 14:25 ET
Merit Medical Receives FDA “Breakthrough Device Designation” for Embosphere® Microspheres for Use in Genicular Artery Embolization for Symptomatic Knee Osteoarthritis
2022-02-24 21:05 ET
Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
2022-01-17 21:55 ET
Merit Medical Systems to Announce Fourth Quarter and Year End 2021 Results on February 24, 2022
2021-10-28 20:05 ET
Merit Medical Reports Results For Quarter Ended September 30, 2021
2021-10-05 21:47 ET
Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
2021-09-20 13:25 ET
Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis
2021-08-16 20:05 ET
Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard
2021-07-29 20:05 ET
Merit Medical Reports Results for Quarter Ended June 30, 2021
2021-07-09 20:05 ET
Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
2021-04-29 20:05 ET
Merit Medical Reports Results for Quarter Ended March 31, 2021
2021-04-09 13:25 ET
Merit Medical Systems to Announce First Quarter Results on April 29, 2021
2021-04-08 13:25 ET
Merit Medical to Present at 20th Annual Needham Healthcare Conference
2021-03-11 20:28 ET
First Patients Enrolled in the Merit WRAPSODY AV Access Efficacy Pivotal Study
2021-02-24 21:05 ET
Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2020, Issues FY 2021 Guidance
2021-02-12 18:00 ET
Merit Medical Systems to Announce Fourth Quarter and Year End 2020 Results on February 24, 2021
2021-02-10 19:00 ET
Merit Medical to Present at 2021 SVB Leerink Global Healthcare Conference
2021-01-07 21:33 ET
Merit Medical to Participate in Two Upcoming Investor Conferences
2020-11-10 21:05 ET
Merit Medical to Present “Foundations for Growth” Program and Financial Targets for 2020 to 2023
2020-10-28 20:05 ET
Merit Medical Reports Results for Third Quarter; Issues Updated 2020 Guidance
2020-10-13 20:05 ET
Merit Medical Systems Finalizes Resolution with the Government
2020-10-09 13:25 ET
Merit Medical Systems to Announce Third Quarter Results on October 28, 2020 and Host “Foundations for Growth” Investor Call on November 10, 2020
2020-09-02 21:30 ET
Merit Medical to Participate at Four Conferences in September
2020-08-06 20:05 ET
Merit Medical to Participate at Canaccord Genuity and Needham Conferences
2020-07-29 20:05 ET
Merit Medical Reports Results for Quarter Ended June 30, 2020
2020-07-17 13:25 ET
Merit Medical Systems to Announce Second Quarter Results on July 29, 2020
2020-07-15 13:25 ET
Merit Medical Announces Agreement in Principle with Department of Justice
2020-05-26 20:01 ET
Merit Medical Announces Agreement With Starboard
2020-05-26 13:25 ET
Merit Medical Receives CE Mark for Wrapsody™ Endovascular Stent Graft System
2020-04-23 20:01 ET
Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance
2020-04-20 13:25 ET
MERIT MEDICAL SYSTEMS DESIGNS AND PRODUCES SAMPLE COLLECTION AND TRANSPORT KIT
2020-04-14 20:05 ET
Merit Medical Systems to Announce First Quarter Results on April 23, 2020
2020-04-06 13:25 ET
MERIT MEDICAL RECEIVES TWO ADDITIONAL FDA BREAKTHROUGH DEVICE DESIGNATIONS
2020-04-03 21:38 ET
MERIT MEDICAL PROVIDES HISTORICAL REVENUES IN REVISED PRESENTATION FORMAT
2020-03-18 14:30 ET
Merit Medical Response to Earthquake in Salt Lake City
2020-03-02 14:25 ET
Merit Medical to Present at Oppenheimer and BTIG Conferences
2020-02-24 21:04 ET
Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance
2020-02-20 14:25 ET
Merit Medical Systems Announces Four Regulatory Approvals
2020-02-18 21:01 ET
Merit Medical to Present at SVB Leerink Conference
2020-02-13 14:25 ET
Merit Medical Systems to Announce Fourth Quarter and Year End 2019 Results on February 24, 2020
2020-01-27 23:17 ET
Merit Medical Issues Statement Regarding Director Nominations From Starboard
2019-12-11 22:30 ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Merit Medical Systems and Net 1 UEPS Technologies and Encourages Investors to Contact the Firm
2019-12-06 15:00 ET
SHAREHOLDER ALERT - Merit Medical Systems, Inc. (MMSI) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Plaintiff Deadline: February 3, 2020
2019-12-05 21:30 ET
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Merit Medical Systems, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - MMSI
2019-11-21 14:25 ET
Merit Medical Receives FDA Breakthrough Device Designation for WRAPSODY™ Endovascular Stent Graft System
2019-11-06 21:05 ET
Merit Medical to Participate at Three Upcoming Conferences
2019-10-30 20:01 ET
Merit Medical Reports Earnings for Third Quarter of 2019
2019-10-18 13:25 ET
Merit Medical Systems to Announce Third Quarter Results on October 30, 2019
2019-08-06 14:00 ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Merit Medical Systems, Inc. (MMSI)

SEC forms

Show financial reports only

SEC form 10
2024-04-30 16:15 ET
Merit Medical Systems reported for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 10
2024-04-30 00:00 ET
Merit Medical Systems published news for 2024 q1
SEC form 10
2024-02-28 17:07 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems reported for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 10
2023-10-26 16:25 ET
Merit Medical Systems published news for 2023 q3
SEC form 8
2023-10-26 16:16 ET
Merit Medical Systems reported for 2023 q3
SEC form 10
2023-10-26 00:00 ET
Merit Medical Systems published news for 2023 q3
SEC form 10
2023-07-28 00:00 ET
Merit Medical Systems published news for 2023 q2
SEC form 6
2023-07-25 16:46 ET
Merit Medical Systems reported for 2023 q2
SEC form 8
2023-07-25 00:00 ET
Merit Medical Systems published news for 2023 q2
SEC form 6
2023-06-29 14:09 ET
Merit Medical Systems published news for 2023 q1
SEC form 6
2023-06-08 16:37 ET
Merit Medical Systems published news for 2023 q1
SEC form 6
2023-06-07 18:14 ET
Merit Medical Systems published news for 2023 q1
SEC form 10
2023-04-28 00:00 ET
Merit Medical Systems published news for 2023 q1
SEC form 8
2023-04-26 00:00 ET
Merit Medical Systems reported for 2023 q1
SEC form 6
2023-02-28 16:23 ET
Merit Medical Systems published news for 2022 q4
SEC form 10
2023-02-24 16:45 ET
Merit Medical Systems reported for 2022 q4
SEC form 10
2023-02-24 00:00 ET
Merit Medical Systems reported for 2022 q4
SEC form 6
2023-02-22 16:55 ET
Merit Medical Systems published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Merit Medical Systems reported for 2022 q4
SEC form 6
2022-11-02 16:21 ET
Merit Medical Systems published news for 2022 q3
SEC form 10
2022-10-28 15:04 ET
Merit Medical Systems reported for 2022 q3
SEC form 10
2022-10-28 00:00 ET
Merit Medical Systems reported for 2022 q3
SEC form 6
2022-10-26 16:41 ET
Merit Medical Systems published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
Merit Medical Systems reported for 2022 q3
SEC form 6
2022-09-01 16:04 ET
Merit Medical Systems published news for 2022 q2
SEC form 10
2022-08-05 16:18 ET
Merit Medical Systems reported for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Merit Medical Systems reported for 2022 q2
SEC form 6
2022-07-27 16:47 ET
Merit Medical Systems published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
Merit Medical Systems reported for 2022 q2
SEC form 6
2022-06-29 12:11 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-06-02 21:59 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-26 17:59 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-26 17:57 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-25 15:57 ET
Merit Medical Systems published news for 2022 q1
SEC form 10
2022-05-06 13:54 ET
Merit Medical Systems reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Merit Medical Systems reported for 2022 q1
SEC form 6
2022-04-29 18:58 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-04-27 16:46 ET
Merit Medical Systems published news for 2022 q1
SEC form 8
2022-04-27 00:00 ET
Merit Medical Systems reported for 2022 q1
SEC form 6
2022-04-22 17:00 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-04-07 16:16 ET
Merit Medical Systems published news for 2022 q1
SEC form 10
2022-03-01 12:56 ET
Merit Medical Systems published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Merit Medical Systems published news for 2021 q4
SEC form 6
2022-02-24 16:44 ET
Merit Medical Systems published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Merit Medical Systems published news for 2021 q4
SEC form 6
2021-11-24 12:14 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-11-05 16:53 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
Merit Medical Systems published news for 2021 q3
SEC form 6
2021-10-28 16:40 ET
Merit Medical Systems published news for 2021 q3
SEC form 8
2021-10-28 00:00 ET
Merit Medical Systems published news for 2021 q3
SEC form 6
2021-10-22 16:36 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-08-06 15:42 ET
Merit Medical Systems published news for 2021 q2
SEC form 10
2021-08-06 00:00 ET
Merit Medical Systems published news for 2021 q2
SEC form 6
2021-07-29 16:45 ET
Merit Medical Systems published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
Merit Medical Systems published news for 2021 q2
SEC form 6
2021-06-29 13:48 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-06-23 16:40 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-06-21 19:07 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-05-07 13:48 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-04-30 16:40 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-04-29 16:45 ET
Merit Medical Systems published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-03-01 12:51 ET
Merit Medical Systems published news for 2020 q4
SEC form 6
2021-02-24 16:39 ET
Merit Medical Systems published news for 2020 q4
SEC form 6
2020-12-21 18:57 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-11-10 16:47 ET
Merit Medical Systems published news for 2020 q3
SEC form 10
2020-11-05 15:55 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-10-28 16:34 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-10-16 17:28 ET
Merit Medical Systems published news for 2020 q3